Search by Drug Name or NDC
NDC 23155-0055-19 naratriptan 2.5 mg/1 Details
naratriptan 2.5 mg/1
naratriptan is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The primary component is NARATRIPTAN HYDROCHLORIDE.
MedlinePlus Drug Summary
Naratriptan is used to treat the symptoms of migraine headaches (severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound or light). Naratriptan is in a class of medications called selective serotonin receptor agonists. It works by narrowing blood vessels around the brain, stopping pain signals from being sent to the brain, and stopping the release of certain natural substances that cause pain, nausea, and other symptoms of migraine. Naratriptan does not prevent migraine attacks or reduce the number of headaches you have.
Related Packages: 23155-0055-19Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Naratriptan
Product Information
| NDC | 23155-0055 |
|---|---|
| Product ID | 23155-055_180ad605-bfed-4db4-ad04-aa7b9fd36f62 |
| Associated GPIs | 67406050100320 |
| GCN Sequence Number | 031492 |
| GCN Sequence Number Description | naratriptan HCl TABLET 2.5 MG ORAL |
| HIC3 | H3F |
| HIC3 Description | ANTIMIGRAINE PREPARATIONS |
| GCN | 81111 |
| HICL Sequence Number | 013266 |
| HICL Sequence Number Description | NARATRIPTAN HCL |
| Brand/Generic | Generic |
| Proprietary Name | naratriptan |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | naratriptan |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | NARATRIPTAN HYDROCHLORIDE |
| Labeler Name | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Pharmaceutical Class | Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA200502 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 23155-0055-19 (23155005519)
| NDC Package Code | 23155-055-19 |
|---|---|
| Billing NDC | 23155005519 |
| Package | 9 TABLET in 1 BLISTER PACK (23155-055-19) |
| Marketing Start Date | 2011-03-15 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.30716 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | NARATRIPTAN HCL 2.5 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |